![laboratory staff testing for antibodies against the influenza virus Close up of testing of samples in a laboratory](https://cdn.who.int/media/images/default-source/who_homepage/laboratory-staff-testing-for-antibodies-against-the-influenza-virus.jpg?sfvrsn=4c9d21fd_2)
Avian Influenza A (H9N2) - India
One of the six WHO Regions, WHO South-East Asia is home to over a quarter of the world’s population.
Committed to building a better, healthier future for the nearly two billion people in the Region, WHO is working with the 11 Member States to address persisting and emerging epidemiological and demographic challenges.
Saima Wazed
Health emergencies:
Featured publications
All →The WHO Regional Director for South-East Asia, Saima Wazed, assumed office on 1 February 2024. Within 100 days, Ms Wazed has rolled out a defining vision...
The burden of mental health conditions in the Region is high and actions are being taken by WHO to address this issue. These include the PARO Declaration...
The One Health (OH) High-Level Expert Panel (OHHLEP) of the Quadripartite Organizations defined OH as an integrated, unifying approach that aims to sustainably...
Featured activities
All →Emergencies
Regional Director Ms Saima Wazed visits Thailand
The Global Leprosy Programme (GLP) of the World Health Organization is housed in the WHO Regional Office for South-East Asia (and not in the Organization’s headquarters in Geneva). It is the Organization’s designated programme for addressing leprosy worldwide. Being classified as one of the 20 neglected tropical diseases (NTDs), the unit works in close collaboration with the Department of Control of NTDs in HQ, designated focal points in all regions, national leprosy programmes and partners.